-+ 0.00%
-+ 0.00%
-+ 0.00%

SHARES OF PHARVARIS UP 26.5% PREMARKET AFTER CO'S GENETIC DISORDER DRUG MEETS MAIN GOAL IN LATE-STAGE TRIAL

Reuters·09/08/2026 11:17:55

Please log in to view news